Rejected at 2:53 p.m. Oct, 31, 2023 ]
Author: medstudent123
Related Note: 1504364393376
Rationale for change

Missing l

Rejection reason

Added via Anki desktop

Text Text
Physeo Physeo
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Gout Drugs
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize




Bootcamp
Watch associated Bootcamp video - Inflammatory Diseases of the Skin: Reactive Disease




Watch associated Bootcamp video - Pharmacology : Gout Medications
OME

Additional Resources


Toxic epidermal necrolysis/Stevens-Johnson syndrome
This 6-month-old patient presents with toxic epidermal necrolysis, the severe form of Stevens-Johnson syndrome.
Smallpox vaccination can trigger toxic epidermal necrolysis.

Stevens-Johnson syndrome following sulfonamide treatment
Blistering of skin and epidermal detachment involving the conjunctiva are visible, resembling a superficial burn.

One by one
Empty field
#AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs #AK_Step1_v12::#B&B::14_MSK::03_Pathology::07_Gout_Drugs::Extra #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::05_Gout_Medications #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::01_Chronic_gout_drugs_(preventive)::*Probenecid #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::08_Acute_and_Chronic_Gout_Treatment #AK_Step1_v12::$AnKingUpdates::$Errata::v12 #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#Bootcamp::Dermatology::03_Inflammatory_Diseases_of_the_Skin::02_Reactive_Disease #PANCE::DERM::acneiform_eruptions #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::13_Allopurinol/Febuxostat #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::14_Probenecid #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::02_Musculoskeletal::03_Dermatology::05_Skin_and_Soft_Tissue_Infections #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs::zanki_extra #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::08_Drug_reactions-musculoskeletal/skin/connective_tissue #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::01_Chronic_gout_drugs_(preventive)::*Allopurinol_Febuxostat #PANCE::EOR::Family_med #PANCE::EOR::IM #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::15_Sulfa_drugs #AK_Step1_v12::#OME::04_Organ_Systems::02_Musculoskeletal::03_Dermatology::05_Skin_and_Soft_Tissue_Infections !AK_UpdateTags::Step1decks::Lolnotacop::Drugs